Literature DB >> 833580

Desynchronization of electrical activity in rats induced by deprenyl--an inhibitor of monoamine oxidase B--and relationship with selective increase of dopamine and beta-phenylethylamine.

M R Dzoljic, J Bruinvels, I L Bonta.   

Abstract

Electrophysiological and biochemical effects of deprenyl and beta-phenylethylamine were studied in rats. d,1-Deprenyl, 1-deprenyl (4-6 mg/kg) and beta-phenylethylamine (75 mg/kg) induced a desynchronization of ECOG after i.p. administration of drugs. The effects lasted several hours. The biochemical analysis indicate that d,1-deprenyl (4 mg/kg) nearly doubled the concentration of brain dopamine (DA) while the concentration of noradrenaline was not altered. The maximal increase was reached at 60 min and the enhanced concentration of DA stayed at this level up till 180 min after administration of drug. Treatment of rats with alpha-methyl-p-tyrosine (200 mg/kg) did not antagonize a deprenyl induced desynchronization of ECOG. However, even low dose of haloperidol (0.1 mg/kg) abolished the arousal effect of d,1-deprenyl and beta-phenylethylamine. It is suggested that desynchronization of EEG induced by deprenyl is more likely due to increased endogenous beta-phenylethylamine than to increased concentration of endogenous DA in the brain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833580     DOI: 10.1007/BF01250275

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  24 in total

1.  EEG effect of intracarotid or intravertebral arterial administration of d-amphetamine in rabbits with basilar artery ligation.

Authors:  W G VAN METER; G F AYALA
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1961-06

2.  EEG-synchronizing effect of gamma-hydroxybutyrate and 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) in relation to dopaminergic brain function.

Authors:  M R Dzoljić; I L Bonta; M Godschalk; A Lagendijk; S Stefanko
Journal:  Neuropharmacology       Date:  1975-08       Impact factor: 5.250

Review 3.  Multiple forms of monoamine oxidase: functional significance.

Authors:  M Sandler; M B Youdim
Journal:  Pharmacol Rev       Date:  1972-06       Impact factor: 25.468

4.  The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat.

Authors:  B E Jones; P Bobillier; C Pin; M Jouvet
Journal:  Brain Res       Date:  1973-08-17       Impact factor: 3.252

5.  Involvement of 5-hydroxytryptamine in the cortical synchronization induced by L-DOPA in the rabbit.

Authors:  J M Gaillard; G Bartholini; B Herkert; R Tissot
Journal:  Brain Res       Date:  1974-03-22       Impact factor: 3.252

6.  Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain.

Authors:  H Y Yang; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1973-11       Impact factor: 4.030

7.  The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.

Authors:  H Y Yang; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1974-06       Impact factor: 4.030

8.  Effects of L-DOPA on the EEG and brain amines of unrestrained rats.

Authors:  P D Thut; R H Rech
Journal:  Exp Neurol       Date:  1972-04       Impact factor: 5.330

9.  The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.

Authors:  C Braestrup; H Andersen; A Randrup
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

10.  Brain stem reticular formation and activation of the EEG.

Authors:  G Moruzzi; H W Magoun
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1949-11
View more
  3 in total

1.  Potentiation of central effects of L-dopa by an inhibitor of catechol-O-methyltransferase.

Authors:  J Nuutila; S Kaakkola; P T Männistö
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

2.  Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.

Authors:  P T Männistö; P Tuomainen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

3.  The neuropharmacological profile of N-methyl-N-propargyl-2-aminotetralin: a potent monoamine oxidase inhibitor.

Authors:  B Hazelhoff; J B De Vries; D Dijkstra; W de Jong; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.